Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Biotech company's board changes signal continued growth
June 6th, 2005
TransMolecular, Inc., a biotechnology company focused on cancer drug research, announced that Hans Mueller, PhD, a long-time veteran of the pharmaceuticals industry, and Mark Ahn, PhD, president and chief executive officer of Hana Biosciences, have been elected to the company's board of directors. After 35 years as a senior pharmaceuticals executive, Hans Mueller retired in 2004 and now provides consulting services under HM Consulting. Prior to his retirement, Mueller served for 11 years as Senior VP, Global Business Development for Wyeth Pharmaceuticals with responsibility for worldwide licensing, partnerships, collaborations and divestitures. ...
Source: Biotech Business Week (2005-06-06)
|
